Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
Mei Dong,
Yunlong Yang,
Kayoko Hosaka,
Yun Zhang,
Yuxia Zhao,
Yuxia Zhao
Affiliations
Mei Dong
State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China
Yunlong Yang
Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China
Kayoko Hosaka
Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Yun Zhang
State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China
Yuxia Zhao
State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China
Yuxia Zhao
Department of Traditional Chinese Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China
